Abbott To Sell Generic Drug Unit To Mylan For $5.3 Billion

Employees walk near an Abbott Laboratories sign at the company's headquarters complex in Abbott Park, Illinois, U.S., on Monday, July 14, 2014. Abbott Laboratories said it plans to sell its generic drug business for established markets to Mylan Inc., getting in return a share of the newly combined companies in a deal valued at about $5.3 billion. Photographer: Daniel Acker/Bloomberg via Getty Images
Employees walk near an Abbott Laboratories sign at the company's headquarters complex in Abbott Park, Illinois, U.S., on Monday, July 14, 2014. Abbott Laboratories said it plans to sell its generic drug business for established markets to Mylan Inc., getting in return a share of the newly combined companies in a deal valued at about $5.3 billion. Photographer: Daniel Acker/Bloomberg via Getty Images
Abbott To Sell Generic Drug Unit To Mylan For $5.3 Billion
PURCHASE A LICENSE
How can I use this image?
$575.00
CAD

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
452152892
Collection:
Bloomberg
Date created:
July 14, 2014
Upload date:
License type:
Release info:
Not released. More information
Source:
Bloomberg
Object name:
ABBOTT MYLAN